DMC Stock Overview
Manufactures, trades in, and imports pharmaceutical products, materials and sub-materials, medical tools, equipment, and chemicals in Vietnam.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Domesco Medical Import - Export Joint-Stock Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫70,000.00 |
| 52 Week High | ₫72,000.00 |
| 52 Week Low | ₫54,000.00 |
| Beta | 0.54 |
| 11 Month Change | 11.11% |
| 3 Month Change | 5.11% |
| 1 Year Change | 10.94% |
| 33 Year Change | 44.48% |
| 5 Year Change | -10.26% |
| Change since IPO | 36.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| DMC | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | 4.9% | -2.7% | -2.9% |
| 1Y | 10.9% | 11.6% | 2.1% |
Return vs Industry: DMC matched the VN Pharmaceuticals industry which returned 11.6% over the past year.
Return vs Market: DMC exceeded the VN Market which returned 2.1% over the past year.
Price Volatility
| DMC volatility | |
|---|---|
| DMC Average Weekly Movement | 3.3% |
| Pharmaceuticals Industry Average Movement | 4.8% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in VN Market | 7.9% |
| 10% least volatile stocks in VN Market | 2.8% |
Stable Share Price: DMC has not had significant price volatility in the past 3 months.
Volatility Over Time: DMC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 956 | Giang Thi Luong | www.domesco.com |
Domesco Medical Import - Export Joint-Stock Corporation manufactures, trades in, and imports pharmaceutical products, materials and sub-materials, medical tools, equipment, and chemicals in Vietnam. The company offers synthetic drug products, including cardiovascular agents, antidiabetics, antibiotics, analgesics and antipyretic drugs, respiratory agents, gastrointestinal drugs, minerals and vitamins, and other synthetic drug products; and herbal, food, dietary supplement, and anti-epidemic products. It also provides pure, mineral, and medical water; and nutritional material and products, as well as purchases, cultivates, and processes medical herbs.
Domesco Medical Import - Export Joint-Stock Corporation Fundamentals Summary
| DMC fundamental statistics | |
|---|---|
| Market cap | ₫2.29t |
| Earnings (TTM) | ₫176.23b |
| Revenue (TTM) | ₫1.79t |
13.8x
P/E Ratio1.4x
P/S RatioIs DMC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DMC income statement (TTM) | |
|---|---|
| Revenue | ₫1.79t |
| Cost of Revenue | ₫1.39t |
| Gross Profit | ₫404.25b |
| Other Expenses | ₫228.01b |
| Earnings | ₫176.23b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.07k |
| Gross Margin | 22.53% |
| Net Profit Margin | 9.82% |
| Debt/Equity Ratio | 0% |
How did DMC perform over the long term?
See historical performance and comparison